The project, called Home for Lunch, began with orthopaedic consultant Sam Oussedik's unhappiness over delays to elective operations because no beds on a ward were available. Tara Donnelly, director of quality, efficiency, and productivity at UCLH, explains. "You can't generally start an elective operation until a bed has been identified as available for that patient. You can have a full team ready to go, the patient prepared, and then you have to wait. It's a huge waste of prime operating time." This could be avoided by making sure patients ready for discharge leave earlier in the day, but arranging that isn't straightforward. The answer found at UCLH was to hold a daily meeting of a large team-doctors, therapists, pharmacists, nurses, and others-every day at 2 pm, for a quarter of an hour. At this meeting patients ready for discharge the next day are identified, and doctors encouraged to get on with prescribing the medicines they will need to take away with them, since the biggest delay identified was patients waiting for the pharmacy to deliver their pills.
The scheme reduced operating delays to zero, cut costs for late booking of transport, and delighted patients. Starting in one ward, it has now spread to nine. "The tricky bit is to make sure it keeps going," says Donnelly. "It needs encouragement and support."
Dean Street Express
Not far away in Dean Street in Soho, a new approach to screening for sexually transmitted infections also makes a virtue of saving time. "We need more frequent testing," says Alan McOwan of Chelsea and Westminster Hospital, lead clinician at the centre. "But lots of services are not very user friendly. You've got to make it simple and quick." At Dean Street Express clients enter their own details, including sexual history and a mobile phone number, via a touch screen. "People love it," says McOwan. "It's a huge relief not to have to tell your sexual history to somebody else, and everyone's quite familiar with touchscreens these days." Then the clients take throat swabs themselves, guided by a video screen mounted in a mirror so that the video can be watched and the actions copied in the mirror-a reassurance that they are doing it right. The swabs are put in a canister by the client, and sent by vacuum tube direct to a Cepheid Infinity automatic testing machine for rapid analysis. The client is then called for blood and HIV tests, if appropriate.
A typical visit takes only half an hour, compared to two hours before the redesign, and results are sent via text message within four hours, rather than the eight days it took to be notified under the old system. "What really excited us was getting people's results so much faster," McOwan says. "In eight days, for every two people who are infected but waiting for test results, one new person will become infected. We can break that chain." The service is very popular and has attracted worldwide interest.
Outpatient management of pneumothorax
A patient helped to advance another innovation shortlisted for the award-the treatment of patients with pneumothorax at home rather than in hospital. "This man had an underlying lung condition, and complained to his GP he was out of breath," recalls Raja Reddy of Kettering General Hospital. "He was referred for an x ray, and cycled six miles to the hospital. When he got here he was x rayed, found to have pneumothorax, and admitted as an emergency."
The team at Kettering had already been trialling home treatment of pneumothorax for patients without underlying disease (so called primary spontaneous cases) but this particular patient wanted the same care. This involves fitting a drain with a small valve to allow the air to leak out, training the patients how to use it, and discharging them home. All primary cases get this care, but the team had been cautious about extending it to secondary cases with underlying disease. Treating pneumothorax at home saves on average four bed days per patient and is just as effective as inpatient treatment. About half the 5000 patients admitted to NHS hospitals each year with pneumothorax could be treated this way.
Ebola virus disease treatment unit
Treating Ebola virus disease would be a tough challenge anywhere, the more so in the circumstances of west Africa. The UK military team tasked with the job of creating a 12 bed facility for treating healthcare workers in Sierra Leone played a key part in encouraging UK doctors and nurses to volunteer in the knowledge that they would be treated as well as humanly possible if they did acquire the infection.
Paul Rees, surgeon commander in the Royal Navy and consultant cardiologist at Barts and the London NHS Trust, says the first key task was making sure all the components needed for the facility were found and delivered to where they were needed. The second was providing care in searing heat, with two to three layers of gloves and cumbersome protective clothing. "We'd all done tours in Iraq and Afghanistan, but this was something very different," he says. "Procedures that would normally take five minutes would take 25."
In practice the unit treated patients other than health workers if beds were available. Despite taking in tertiary referrals from other units, in its first 60 days the unit achieved a survival rate of 55%.This compares well with survival rates overall, says Rees. "Despite accepting those patients, we did better than average."
Innovations in prostate cancer
Taking a fresh look at the entire patient pathway in prostate cancer has led to better diagnoses, fewer and better biopsies, and a vastly improved patient experience, says Hashim Ahmed of University College London, an honorary consultant urologist at UCLH NHS Foundation Trust. It is an approach that has now been adopted by more than 40 other centres in the UK and abroad.
At the heart of the change is better diagnosis. "Prostate cancer historically has been the only solid cancer that relied on random biopsies for diagnosis," Ahmed says. "They have been taken through the back passage with no knowledge of the cancer location. Bleeding, pain, and life threatening infections can occur, and the random needle deployment leads to 30% of cancers being missed and indolent cancers detected by chance."
At UCLH, highly accurate magnetic resonance imaging allows men without cancer to avoid biopsy, while those with a suspicious lesion can have an accurately targeted biopsy, carried out through the skin and virtually eliminating infection. A one stop diagnostic service allows men to be reviewed, scanned, and, if necessary, biopsied in one day. Men undergoing active surveillance can have MRI, as opposed to transrectal biopsies. More accurately targeted therapies have also been pioneered.
"It was a challenge to do all these things," says Ahmed. "But we now have 30% fewer biopsies, 30% better cancer detection, fewer radical treatments, a greater number of day case treatments, and fewer complications and side effects. The next step is to get this new pathway adopted across Europe."
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